Trademarkia Logo

United Kingdom

£
Trademark Search
CTX001

View On IPO.GOV.UK

Registered

on 9 Oct 2018

Last Applicant/ Owned by

Vertex Pharmaceuticals Incorporated

50 Northern Avenue, Boston, Massachusetts 02210

, ,

Serial Number

UK00801471636 filed on 9th Oct 2018

Registration Number

UK00801471636 registered on
15th Nov 2019

Correspondent Information

Stobbs

Building 1000, Cambridge Research Park

Cambridge,

CB25 9PD

CTX001

cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of sickle cell disease and b-thalassemi; pharmaceutic Read More

Classification Information

Class [5]
Pharmaceutical Products

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of sickle cell disease and b-thalassemi; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders.

Class [10]
Medical Instrument Products

Gene therapy apparatus and instruments, namely, surgical, medical apparatus and instruments for gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; surgical, medical apparatus and instruments for gene editing.

Class [42]
Computer & Software Services & Scientific Services

Gene editing (terms considered too vague by the International Bureau – Rule 13 (2) (b) of the Common Regulations).

Mark Details

Serial Number

UK00801471636

Mark Type

Word

Kind of mark

Individual